Airway management

Propofol versus ketamine in rapid sequence intubation in critically ill patients: a prospective, randomized, controlled trial

Intensive Care MedPublished Randomised controlled trial

Primary resultResult — go to the resultMean difference 6.0 95% CI - 0.0 to 11.9

Authors' conclusion

Among critically ill patients undergoing RSI, Ketamine resulted in a less pronounced decrease in MAP in the first 10 min compared with propofol, but the difference was not clinically meaningful or sustained.

Study context

Population
Critically ill adults (≥ 18 years) requiring rapid sequence intubation (RSI) in two mixed ICUs175 in modified ITT analysis
Participants
207 adults
Comparison
Ketamine vs propofol for RSI
  • Ketaminen = 91
  • Propofoln = 84reference
Primary endpoint
Lowest MAP after induction (linear regression adjusted for age, baseline MAP and total vasopressor dose within 10 min)
Follow-up
First 10 min after induction
Methodological detailsinvestigator-initiated, open-label, two-centre, October 2021 to October 2023
  • Investigator-initiated
  • Open-label
  • Two-centre
  • October 2021 to October 2023

Primary result

As reported in the abstract

Mean difference

6.0

95% CI - 0.0 to 11.9

P = 0.050

By group

Ketamine vs Propofol
mean difference 6.0 (95% CI - 0.0 to 11.9); P = 0.050

Further findings

Cardiovascular collapse

OutcomeKetaminePropofolOR (95% CI)
Mortality · Day 733%23.8%1.38 (0.86–2.24)
Hospital mortality60.4%50.0%1.21 (0.92–1.58)
  • Cardiovascular collapse: mainly due to an increase in the vasopressor dose within 2 min

Average mean arterial pressure (MAP) difference · first hour

Average MAP difference over the first hour
1.67 (95% CI - 1.98 to 5.31)

Safety

Cardiovascular collapse

  • Cardiovascular collapse: mainly due to an increase in the vasopressor dose within 2 min

Original publication

Propofol versus ketamine in rapid sequence intubation in critically ill patients: a prospective, randomized, controlled trial. Intensive Care Med. Published 23 March 2026. doi:10.1007/s00134-026-08351-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.